These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 38427489)
1. Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons. Gohel D; Zhang P; Gupta AK; Li Y; Chiang CW; Li L; Hou Y; Pieper AA; Cummings J; Cheng F J Alzheimers Dis; 2024; 98(2):643-657. PubMed ID: 38427489 [TBL] [Abstract][Full Text] [Related]
2. Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease. Fang J; Zhang P; Zhou Y; Chiang CW; Tan J; Hou Y; Stauffer S; Li L; Pieper AA; Cummings J; Cheng F Nat Aging; 2021 Dec; 1(12):1175-1188. PubMed ID: 35572351 [TBL] [Abstract][Full Text] [Related]
5. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060 [TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079 [TBL] [Abstract][Full Text] [Related]
7. Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation. Chang KH; Lee-Chen GJ; Huang CC; Lin JL; Chen YJ; Wei PC; Lo YS; Yao CF; Kuo MW; Chen CM Mol Neurobiol; 2019 Jun; 56(6):3972-3983. PubMed ID: 30238389 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer's Disease Neurons. van der Kant R; Langness VF; Herrera CM; Williams DA; Fong LK; Leestemaker Y; Steenvoorden E; Rynearson KD; Brouwers JF; Helms JB; Ovaa H; Giera M; Wagner SL; Bang AG; Goldstein LSB Cell Stem Cell; 2019 Mar; 24(3):363-375.e9. PubMed ID: 30686764 [TBL] [Abstract][Full Text] [Related]
9. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F). Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003 [TBL] [Abstract][Full Text] [Related]
10. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease. Sahlgren Bendtsen KM; Hall VJ Cells; 2023 Jan; 12(3):. PubMed ID: 36766763 [TBL] [Abstract][Full Text] [Related]
12. Using Big Data to Uncover Association Between Sildenafil Use and Reduced Risk of Alzheimer's Disease. Huo X; Finkelstein J Stud Health Technol Inform; 2023 May; 302():866-870. PubMed ID: 37203519 [TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain. Aulston B; Liu Q; Mante M; Florio J; Rissman RA; Yuan SH J Alzheimers Dis; 2019; 72(2):575-585. PubMed ID: 31594233 [TBL] [Abstract][Full Text] [Related]
14. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons. Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses. Podvin S; Jones A; Liu Q; Aulston B; Ransom L; Ames J; Shen G; Lietz CB; Jiang Z; O'Donoghue AJ; Winston C; Ikezu T; Rissman RA; Yuan S; Hook V Mol Cell Proteomics; 2020 Jun; 19(6):1017-1034. PubMed ID: 32295833 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons. Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485 [TBL] [Abstract][Full Text] [Related]
17. RNA-binding protein ELAVL4/HuD ameliorates Alzheimer's disease-related molecular changes in human iPSC-derived neurons. van der Linden RJ; Gerritsen JS; Liao M; Widomska J; Pearse RV; White FM; Franke B; Young-Pearse TL; Poelmans G Prog Neurobiol; 2022 Oct; 217():102316. PubMed ID: 35843356 [TBL] [Abstract][Full Text] [Related]
18. Exploring the Multifaceted Potential of Sildenafil in Medicine. Pușcașu C; Zanfirescu A; Negreș S; Șeremet OC Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138293 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients. Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602 [TBL] [Abstract][Full Text] [Related]
20. Tau depletion in human neurons mitigates Aβ-driven toxicity. Ng B; Vowles J; Bertherat F; Abey A; Kilfeather P; Beccano-Kelly D; Stefana MI; O'Brien DP; Bengoa-Vergniory N; Carling PJ; Todd JA; Caffrey TM; Connor-Robson N; Cowley SA; Wade-Martins R Mol Psychiatry; 2024 Jul; 29(7):2009-2020. PubMed ID: 38361127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]